Endnotes

1. GOV.UK. 999 and 112: the UK’s national emergency numbers. Available at: https://www.gov.uk/guidance/999-and-112-the-uks-national-emergency-numbers
2. European Commission. 112 - emergency number. Available at: https://digital-strategy.ec.europa.eu/en/policies/112
3. National Institute for Health and Care Excellence (NICE). Alcohol-use disorders: diagnosis and management of physical complications (CG100) – Recommendations. Available at: https://www.nice.org.uk/guidance/cg100/chapter/recommendations
4. World Health Organization. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Available at: https://www.who.int/publications/i/item/WHO-MSD-MSB-01.6a Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT Alcohol Consumption Questions (AUDIT-C): An Effective Brief Screening Test for Problem Drinking. Available at: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/208954
5. International Agency for Research on Cancer (IARC). Alcohol Consumption and Ethyl Carbamate. Available at: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Alcohol-Consumption-And-Ethyl-Carbamate-2010
6. Specialist Pharmacy Service (SPS). Using and prescribing thiamine in alcohol dependence. Available at: https://www.sps.nhs.uk/articles/using-and-prescribing-thiamine-in-alcohol-dependence/
7. British National Formulary (BNF); NICE. Alcohol dependence | Treatment summaries | BNF | NICE. Available at: https://bnf.nice.org.uk/treatment-summaries/alcohol-dependence/
8. National Institute for Health and Care Excellence (NICE). Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence (CG115). Available at: https://www.nice.org.uk/guidance/cg115
9. National Institute for Health and Care Excellence (NICE). Nalmefene for reducing alcohol consumption in people with alcohol dependence (TA325) – 1 Guidance. Available at: https://www.nice.org.uk/guidance/ta325/chapter/1-guidance
10. Chakravorty S, Chaudhary NS, Brower KJ. Alcohol and Sleep I: Effects on Normal Sleep. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5821259/
11. Heilig M, Egli M. Protracted Alcohol Withdrawal Syndrome: The Search for the Elusive Syndrome. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9798382/
12. Birdee G, et al. Slow breathing for reducing stress: The effect of extending exhale. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10395759/

References & Sources

1. American Psychiatric Association (2018) The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Washington, DC: American Psychiatric Association.
2. Babor, T.F., Higgins-Biddle, J.C., Saunders, J.B. and Monteiro, M.G. (2001) AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for use in primary care. 2nd edn. Geneva: World Health Organization.
3. Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, L., Jenab, M., Turati, F., Pasquali, E., Pelucchi, C., Galeone, C., Bellocco, R., Negri, E., Corrao, G., Boffetta, P. and La Vecchia, C. (2015) ‘Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis’, British Journal of Cancer, 112, pp. 580–593. doi:10.1038/bjc.2014.579.
4. Beck, A.T. (1979) Cognitive therapy and the emotional disorders. New York: Penguin.
5. Brower, K.J. (2001) ‘Alcohol’s effects on sleep in alcoholics’, Alcohol Research & Health, 25(2), pp. 110–125.
6. Canadian Centre on Substance Use and Addiction (2023) Canada’s guidance on alcohol and health. Ottawa: CCSA.
7. Carroll, K.M. and Onken, L.S. (2005) ‘Behavioral therapies for drug abuse’, American Journal of Psychiatry, 162(8), pp. 1452–1460. doi:10.1176/appi.ajp.162.8.1452.
8. Craske, M.G., Treanor, M., Conway, C.C., Zbozinek, T. and Vervliet, B. (2014) ‘Maximizing exposure therapy: an inhibitory learning approach’, Behaviour Research and Therapy, 58, pp. 10–23. doi:10.1016/j.brat.2014.04.006.
9. Erol, A. and Karpyak, V.M. (2015) ‘Sex and gender-related differences in alcohol use and its consequences’, Alcohol Research: Current Reviews, 38(1), pp. 1–13.
10. GBD 2016 Alcohol Collaborators (2018) ‘Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis’, The Lancet, 392(10152), pp. 1015–1035. doi:10.1016/S0140-6736(18)31310-2.
11. Hofmann, S.G., Asnaani, A., Vonk, I.J.J., Sawyer, A.T. and Fang, A. (2012) ‘The efficacy of cognitive behavioral therapy: a review of meta-analyses’, Cognitive Therapy and Research, 36, pp. 427–440. doi:10.1007/s10608-012-9476-1.
12. Humphreys, K., Blodgett, J.C. and Wagner, T.H. (2014) ‘Estimating the efficacy of Alcoholics Anonymous’, Addiction, 109(2), pp. 206–216. doi:10.1111/add.12416.
13. International Agency for Research on Cancer (2012) Personal habits and indoor combustions. Volume 100E: A review of human carcinogens. Lyon: IARC.
14. Irish, L.A., Kline, C.E., Gunn, H.E., Buysse, D.J. and Hall, M.H. (2015) ‘The role of sleep hygiene in promoting public health’, Sleep Medicine Reviews, 22, pp. 23–36. doi:10.1016/j.smrv.2014.10.001.
15. Jacobsen, L.K., Southwick, S.M. and Kosten, T.R. (2001) ‘Substance use disorders in patients with posttraumatic stress disorder’, American Journal of Psychiatry, 158(8), pp. 1184–1190. doi:10.1176/appi.ajp.158.8.1184.
16. Johnson, B.A., Rosenthal, N., Capece, J.A., Wiegand, F., Mao, L., Beyers, K., McKay, A., Ait-Daoud, N., Anton, R.F. and Ciraulo, D.A. (2007) ‘Topiramate for treating alcohol dependence’, JAMA, 298(14), pp. 1641–1651. doi:10.1001/jama.298.14.1641.
17. Jonas, D.E., Amick, H.R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M.M., Shanahan, E., Gass, C.E., Rowe, C.J. and Garbutt, J.C. (2014) ‘Pharmacotherapy for adults with alcohol use disorders’, JAMA, 311(18), pp. 1889–1900. doi:10.1001/jama.2014.3628.
18. Kaner, E.F.S., Beyer, F.R., Muirhead, C., Campbell, F., Pienaar, E.D., Bertholet, N., Daeppen, J.B., Saunders, J.B. and Burnand, B. (2018) ‘Effectiveness of brief alcohol interventions in primary care’, Cochrane Database of Systematic Reviews, (2). doi:10.1002/14651858.CD004148.pub4.
19. Kelly, J.F., Humphreys, K. and Ferri, M. (2020) ‘Alcoholics Anonymous and other 12-step programs for alcohol use disorder’, Cochrane Database of Systematic Reviews, (3). doi:10.1002/14651858.CD012880.pub2.
20. Kessler, R.C., Sonnega, A., Bromet, E., Hughes, M. and Nelson, C.B. (1995) ‘Posttraumatic stress disorder in the National Comorbidity Survey’, Archives of General Psychiatry, 52(12), pp. 1048–1060. doi:10.1001/archpsyc.1995.03950240066012.
21. Koob, G.F. and Le Moal, M. (2008) ‘Addiction and the brain antireward system’, Annual Review of Psychology, 59, pp. 29–53. doi:10.1146/annurev.psych.59.103006.093548.
22. Linehan, M.M. (2015) DBT skills training manual. 2nd edn. New York: Guilford Press.
23. Mann, K., Bladström, A., Torup, L., Gual, A. and van den Brink, W. (2013) ‘Extending the treatment options in alcohol dependence: a randomized controlled study of nalmefene’, The Lancet, 381(9867), pp. 478–486. doi:10.1016/S0140-6736(12)61955-0.
24. Marlatt, G.A. and Donovan, D.M. (eds) (2005) Relapse prevention: maintenance strategies in the treatment of addictive behaviors. 2nd edn. New York: Guilford Press.
25. Mason, B.J., Quello, S., Goodell, V., Shadan, F., Kyle, M. and Begovic, A. (2014) ‘Gabapentin treatment for alcohol dependence’, JAMA Internal Medicine, 174(1), pp. 70–77. doi:10.1001/jamainternmed.2013.11950.
26. Mayo-Smith, M.F. (1997) ‘Pharmacological management of alcohol withdrawal’, JAMA, 278(2), pp. 144–151. doi:10.1001/jama.1997.03550020076042.
27. Miller, W.R. and Rollnick, S. (2013) Motivational interviewing: helping people change. 3rd edn. New York: Guilford Press.
28. National Health and Medical Research Council (2020) Australian guidelines to reduce health risks from drinking alcohol. Canberra: NHMRC.
29. National Institute for Health and Care Excellence (2010, updated 2017) Alcohol-use disorders: diagnosis and management of physical complications (CG100). London: NICE.
30. National Institute for Health and Care Excellence (2011, updated 2014) Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115). London: NICE.
31. National Institute on Alcohol Abuse and Alcoholism (2021) Helping patients who drink too much: a clinician’s guide. Bethesda, MD: NIAAA.
32. National Institute on Alcohol Abuse and Alcoholism (2022) Alcohol and women. Bethesda, MD: NIAAA.
33. Rehm, J., Baliunas, D., Borges, G.L.G., Graham, K., Irving, H., Kehoe, T., Parry, C.D.H., Patra, J., Popova, S., Poznyak, V. and Roerecke, M. (2010) ‘The relation between different dimensions of alcohol consumption and burden of disease’, Addiction, 105(5), pp. 817–843. doi:10.1111/j.1360-0443.2010.02899.x.
34. Robinson, T.E. and Berridge, K.C. (2008) ‘The incentive sensitization theory of addiction’, Philosophical Transactions of the Royal Society B, 363(1507), pp. 3137–3146. doi:10.1098/rstb.2008.0093.
35. Rosner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S. and Soyka, M. (2010a) ‘Acamprosate for alcohol dependence’, Cochrane Database of Systematic Reviews, (9). doi:10.1002/14651858.CD004332.pub2.
36. Rosner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S. and Soyka, M. (2010b) ‘Naltrexone for alcohol dependence’, Cochrane Database of Systematic Reviews, (12). doi:10.1002/14651858.CD001867.pub3.
37. Saitz, R. (1998) ‘Introduction to alcohol withdrawal’, Alcohol Health & Research World, 22(1), pp. 5–12.
38. Sechi, G. and Serra, A. (2007) ‘Wernicke’s encephalopathy’, The Lancet Neurology, 6(5), pp. 442–455. doi:10.1016/S1474-4422(07)70104-7.
39. Substance Abuse and Mental Health Services Administration (2013) TIP 49: Incorporating alcohol pharmacotherapies into medical practice. Rockville, MD: SAMHSA.
40. Substance Abuse and Mental Health Services Administration (2014) SAMHSA’s concept of trauma and guidance for a trauma-informed approach. Rockville, MD: SAMHSA.
41. Thomson, A.D., Marshall, E.J. and Pratt, O.E. (2012) ‘The treatment of patients at risk of developing Wernicke’s encephalopathy’, Alcohol and Alcoholism, 47(5), pp. 528–530. doi:10.1093/alcalc/ags070.
42. Trauer, J.M., Qian, M.Y., Doyle, J.S., Rajaratnam, S.M.W. and Cunnington, D. (2015) ‘Cognitive behavioral therapy for chronic insomnia’, Annals of Internal Medicine, 163(3), pp. 191–204. doi:10.7326/M14-2841.
43. UK Chief Medical Officers (2016) UK Chief Medical Officers’ low risk drinking guidelines. London: Department of Health.
44. U.S. Department of Veterans Affairs and Department of Defense (2021) VA/DoD clinical practice guideline for the management of substance use disorders. Washington, DC: VA/DoD.
45. World Health Organization (2010) Global strategy to reduce the harmful use of alcohol. Geneva: WHO.
46. World Health Organization (2014) Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva: WHO.
47. World Health Organization (2018) Global status report on alcohol and health 2018. Geneva: WHO.
48. World Health Organization (2024) Global status report on alcohol and health and treatment of substance use disorders. Geneva: WHO.